Axiom Investment Management’s Bristol-Myers Squibb BMY Stock Holding History

Axiom Investment Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$84.1K	Buy	+1,387	New	+$80.9K	0.06%	159
2022 Q4	–	Sell	-86	Closed	-$6K	–	126
2022 Q3	$6K	Buy	+86	New	+$6.24K	0.01%	276
2022 Q1	–	Sell	-10,729	Closed	-$668K	–	99
2021 Q4	$668K	Sell	10,729 -9,248	-46%	-$542K	0.65%	37
2021 Q3	$1.18M	Buy	+19,977	New	+$1.32M	1.19%	20
2021 Q1	–	Sell	-434	Closed	-$214	–	197
2020 Q4	$214	Buy	+434	New	+$26.7K	0.19%	109
2019 Q4	–	Sell	-37,197	Closed	-$1.89M	–	148
2019 Q3	$1.89M	Sell	37,197 -102,803	-73%	-$4.83M	1.44%	16
2019 Q2	$6.36M	Sell	140,000 -518	-0.4%	-$24.1K	1.15%	17
2019 Q1	$6.73M	Buy	140,518 +2,001	+1%	+$99.7K	1.28%	14
2018 Q4	$7.2M	Buy	+138,517	New	+$7.44M	1.52%	13

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Axiom Investment Management's BMY Position: Q1 2026 in Review

Axiom Investment Management opened a new position in Bristol-Myers Squibb (BMY) in Q1 2026: 1,387 shares worth $84.1K. The stake represents 0.06% of the portfolio and ranks #159 among its holdings. This is a return to the name: Axiom Investment Management previously reported a position in BMY as recently as Q3 2022.

Axiom Investment Management first reported a position in BMY in Q4 2018 and has held it in 9 quarters since. The position peaked at $7.2M in Q4 2018. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

Axiom Investment Management held 1,387 shares of Bristol-Myers Squibb worth $84.1K as of Q1 2026.
Bristol-Myers Squibb was a new Axiom Investment Management position in Q1 2026.
Bristol-Myers Squibb made up 0.06% of Axiom Investment Management's portfolio in Q1 2026, its #159 holding.
Axiom Investment Management first reported a position in Bristol-Myers Squibb in Q4 2018 and has held it in 9 quarters since.
Axiom Investment Management's Bristol-Myers Squibb position peaked at $7.2M in Q4 2018.
2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Axiom Investment Management's 13F filing for Q1 2026, filed 26 May 2026.